the invention is drawn to novel macrolide compounds of formula i having antibiotic and antineoplastic activities , useful as medicaments and / or agrochemicals for microorganism infections , in particularly for infectious diseases involving drug - resistant staphylococcus , and for treatment of human and animal cancers .